SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular ...

SANTA CLARA, Calif., Nov. 07, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely ...

A rendering of the Lithoplasty balloon catheter, screenshot--Courtesy of Shockwave Medical Medical device makers are scrambling to develop and sell advanced angioplasty balloons to treat peripheral ...

Shockwave's Lithoplasty System delivers a one-two punch to calcified plaques—it delivers ultrasound shockwaves to break them up and then its angioplasty balloon restores blood flow. (Shockwave Medical ...

Shockwave owns US Patent No. 8,956,371 (the “’371 patent”), which is directed to the treatment of atherosclerosis through intravascular lithotripsy. The claimed device is for a “typical over-the-wire ...

Shockwave Medical, Inc. (“Shockwave”) owns U.S. Patent No. 8,956,371 (“the ’371 patent”). This patent is directed to the treatment of atherosclerosis through intravascular lithotripsy (“IVL”). The ...

ShockWave Medical is an innovative leader changing the way surgeons treat calcified arteries. As the name implies, this company's devices employ powerful sound waves that can break up calcified ...

ShockWave treats artery disease, a buildup of plaque in blood vessel walls. For decades, doctors have used a procedure known as an angioplasty, where a balloon is inserted into the artery and then ...

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. SANTA CLARA, Calif., Nov. 07, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc ...

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here. Shockwave Medical, Inc. (NASDAQ: SWAV) announced today that long-term data ...